Showing results (521-530 of 605) with videos related to

Sort By:
Pageof 61
Annals of Hematology|October 27, 2012
Survival benefit with salvage radiotherapy for patients with locoregionally recurrent extranodal NK/T cell lymphoma, nasal typeTing Zhao, Ye-Xiong Li, Shu-Lian Wang, et al.
Future Oncology (London, England)|January 5, 2024
Multicenter phase II study of moderate low-dose radiotherapy in indolent non-Hodgkin lymphoma: CLCG-iNHL-01 protocolLin-Rui Gao, Xinyue Wang, Changfa Xia, et al.
Breast (Edinburgh, Scotland)|May 2, 2021
Cost-effectiveness of postmastectomy hypofractionated radiation therapy vs conventional fractionated radiation therapy for high-risk breast cancerJing Yang, Shu-Nan Qi, Hui Fang, et al.
Journal of Viral Hepatitis|January 6, 2023
Hepatic steatosis and metabolic risk factors among patients with chronic hepatitis B: The multicentre, prospective CAP-Asia studyYong-Wen Leow, Wah-Kheong Chan, George Boon-Bee Goh, et al.
Chinese Journal of Cancer|May 30, 2012
R-CHOP regimen can significantly decrease the risk of disease relapse and progression in patients with non-germinal center B-cell subtype diffuse large B-cell lymphomaXiao-Hui He, Bo Li, Sheng Yang, et al.
Cardiovascular Research|March 29, 2014
Elevated microRNA-155 promotes foam cell formation by targeting HBP1 in atherogenesisFu-Ju Tian, Li-Na An, Guo-Kun Wang, et al.
Scientific Reports|October 20, 2024
Dosimetric benefit and clinical feasibility of deep inspiration breath-hold and volumetric modulated arc therapy-based postmastectomy radiotherapy for left-sided breast cancerShi-Jia Wang, Yi-Rui Zhai, Wen-Wen Zhang, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 6, 2015
Survival benefit with IMRT following narrow-margin hepatectomy in patients with hepatocellular carcinoma close to major vesselsWei-Hu Wang, Zhi Wang, Jian-Xiong Wu, et al.
Blood|July 25, 2012
Clinical implications of plasma Epstein-Barr virus DNA in early-stage extranodal nasal-type NK/T-cell lymphoma patients receiving primary radiotherapyZhao-Yang Wang, Qing-Feng Liu, Hua Wang, et al.
British Journal of Cancer|March 25, 2023
The prognostic value of tumour-infiltrating lymphocytes, programmed cell death protein-1 and programmed cell death ligand-1 in Stage I-III triple-negative breast cancerGuang-Yi Sun, Jing Zhang, Bing-Zhi Wang, et al.
Pageof 61